The New England
Comparative Effectiveness Public Advisory Council is seeking nominations
for new members. New England CEPAC is a group of clinicians, economists, and
patient/consumer representatives that meets three times each year to take a deep
dive into the evidence on the effectiveness and value of new drugs, devices and
delivery system innovations. At the public meetings, CEPAC hears from experts,
patients affected by the condition being discussed, and other stakeholders.
CEPAC then votes publicly on the merits and value for the New England region of
the studied treatments. CEPAC, and two similar councils in other regions, are
programs of the Institute for Clinical and
Economic Research, an independent nonprofit institute that produces reports
on the evidence for effectiveness of new drugs and other health services.
ICER’s reports are used by a growing list of public and private payers in
maximizing value for every health care dollar. To ensure independence, CEPA
members must meet ICER’s
conflict of interest policies. Nominations can be sent to info@icer-review.org on or before December
1st at 5pm. Please send a CV and letter to interest. Both organization-sponsored
and self-nominations are welcome.
